Overall market sentiment has been neutral on Biocept Inc (BIOC) stock lately. BIOC receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With BIOC Stock Today?
Biocept Inc (BIOC) stock is up 4.45% while the S&P 500 is lower by -1.12% as of 9:59 AM on Monday, Sep 21. BIOC has gained $0.20 from the previous closing price of $4.49 on volume of 153,478 shares. Over the past year the S&P 500 is up 10.95% while BIOC is lower by -45.47%. BIOC lost -$6.00 per share in the over the last 12 months.
To screen for more stocks like Biocept Inc click here.
More About Biocept Inc
Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group.
Click Here to get the full Stock Score Report on Biocept Inc (BIOC) Stock.
